Seguir
Tomasz Stoklosa
Tomasz Stoklosa
Dirección de correo verificada de wum.edu.pl
Título
Citado por
Citado por
Año
Direct tumor damage mechanisms of photodynamic therapy.
D Nowis, M Makowski, T Stokłosa, M Legat, T Issat, J Gołąb
Acta Biochimica Polonica 52 (2), 339-352, 2005
4492005
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
M Koptyra, R Falinski, MO Nowicki, T Stoklosa, I Majsterek, ...
Blood 108 (1), 319-327, 2006
3692006
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species–dependent DNA double-strand breaks
MO Nowicki, R Falinski, M Koptyra, A Slupianek, T Stoklosa, E Gloc, ...
Blood 104 (12), 3746-3753, 2004
3032004
Immunologia
J Gołąb, W Lasek, DA Nowis, T Stokłosa, WN PWN
PWN, 2023
2602023
Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity
D Nowis, M Legat, T Grzela, J Niderla, E Wilczek, GM Wilczynski, ...
Oncogene 25 (24), 3365-3374, 2006
2252006
Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
M Nieborowska-Skorska, PK Kopinski, R Ray, G Hoser, D Ngaba, S Flis, ...
Blood, The Journal of the American Society of Hematology 119 (18), 4253-4263, 2012
2032012
Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice
W Feleszko, I Młynarczuk, EZ Bałkowiec-Iskra, A Czajka, T Switaj, ...
Clinical Cancer Research 6 (5), 2044-2052, 2000
1812000
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20
M Winiarska, J Bil, E Wilczek, GM Wilczynski, M Lekka, PJ Engelberts, ...
PLoS medicine 5 (3), e64, 2008
1572008
The influence of photodynamic therapy on the immune response
D Nowis, T Stokłosa, M Legat, T Issat, M Jakóbisiak, J Gołąb
Photodiagnosis and photodynamic therapy 2 (4), 283-298, 2005
1482005
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
E Bolton-Gillespie, M Schemionek, HU Klein, S Flis, G Hoser, T Lange, ...
Blood, The Journal of the American Society of Hematology 121 (20), 4175-4183, 2013
1342013
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response
A Szokalska, M Makowski, D Nowis, GM Wilczynski, M Kujawa, C Wójcik, ...
Cancer research 69 (10), 4235-4243, 2009
1262009
BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations
T Stoklosa, T Poplawski, M Koptyra, M Nieborowska-Skorska, G Basak, ...
Cancer research 68 (8), 2576-2580, 2008
1252008
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice
W Lasek, W Feleszko, J Goląb, T Stokłosa, M Marczak, A Dąbrowska, ...
Cancer Immunology, Immunotherapy 45, 100-108, 1997
1031997
Synthesis and Optical Properties of Tetraaryl‐1,4‐dihydropyrrolo[3,2‐b]pyrroles
A Janiga, E Glodkowska‐Mrowka, T Stoklosa, DT Gryko
Asian Journal of Organic Chemistry 2 (5), 411-415, 2013
942013
Immunologia
M Jakóbisiak, W Lasek, T Stokłosa, J Gołąb
Wydawnictwo Naukowe PWN, 2020
912020
Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF
J Goląb, G Wilczyński, R Zagożdżon, T Stoklosa, A Dąbrowska, ...
British journal of cancer 82 (8), 1485-1491, 2000
882000
Titin truncating variants in dilated cardiomyopathy–prevalence and genotype-phenotype correlations
M Franaszczyk, P Chmielewski, G Truszkowska, P Stawinski, E Michalak, ...
PLoS One 12 (1), e0169007, 2017
842017
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
D Nowis, M Bugajski, M Winiarska, J Bil, A Szokalska, P Salwa, T Issat, ...
BMC cancer 8, 1-12, 2008
832008
Bright, color-tunable fluorescent dyes based on π-expanded diketopyrrolopyrroles
M Grzybowski, E Glodkowska-Mrowka, T Stoklosa, DT Gryko
Organic letters 14 (11), 2670-2673, 2012
812012
The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
M Kusio-Kobialka, P Podszywalow-Bartnicka, P Peidis, ...
Cell Cycle 11 (21), 4069-4078, 2012
782012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20